Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Prepaid Assets (2017 - 2025)

Aclaris Therapeutics (ACRS) has 9 years of Prepaid Assets data on record, last reported at $4.2 million in Q2 2025.

  • For Q2 2025, Prepaid Assets fell 32.41% year-over-year to $4.2 million; the TTM value through Jun 2025 reached $4.2 million, down 32.41%, while the annual FY2024 figure was $12.0 million, 27.37% up from the prior year.
  • Prepaid Assets reached $4.2 million in Q2 2025 per ACRS's latest filing, up from $3.2 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $19.7 million in Q3 2023 and bottomed at $3.2 million in Q1 2025.
  • Average Prepaid Assets over 5 years is $9.3 million, with a median of $9.0 million recorded in 2021.
  • Peak YoY movement for Prepaid Assets: surged 401.74% in 2021, then crashed 78.32% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $13.0 million in 2021, then increased by 3.85% to $13.5 million in 2022, then dropped by 29.96% to $9.5 million in 2023, then grew by 27.37% to $12.0 million in 2024, then crashed by 65.1% to $4.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $4.2 million in Q2 2025, $3.2 million in Q1 2025, and $12.0 million in Q4 2024.